Access to anti-retroviral drugs, female in IDA only
IDA only: Access to anti-retroviral drugs, female was 86.5% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in IDA only, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in IDA only is 86.5%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 4.3% on the previous year and up 86.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in IDA only peaked at 86.5% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in IDA only, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.1% | +934.5% |
| 2003 | 0.5% | +302.4% |
| 2004 | 1.7% | +221.5% |
| 2005 | 3.5% | +105.5% |
| 2006 | 6.2% | +77.2% |
| 2007 | 10.8% | +72.7% |
| 2008 | 15.0% | +39.3% |
| 2009 | 18.8% | +25.4% |
| 2010 | 23.2% | +23.3% |
| 2011 | 27.2% | +17.2% |
| 2012 | 32.7% | +20.5% |
| 2013 | 38.9% | +18.9% |
| 2014 | 46.3% | +18.8% |
| 2015 | 51.1% | +10.4% |
| 2016 | 56.4% | +10.5% |
| 2017 | 62.7% | +11.1% |
| 2018 | 65.5% | +4.5% |
| 2019 | 69.5% | +6.1% |
| 2020 | 73.6% | +5.9% |
| 2021 | 76.2% | +3.5% |
| 2022 | 79.8% | +4.8% |
| 2023 | 82.9% | +3.9% |
| 2024 | 86.5% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.7% | 0.0% | 18.8% | 10 |
| 2010s | 47.3% | 23.2% | 69.5% | 10 |
| 2020s | 79.8% | 73.6% | 86.5% | 5 |
More gender data for IDA only
- Labor force, female 197.83 million (2025)
- Labor force, female, per capita 0.1525 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.66 % change on previous year (2025)
- Labor force, female, per square kilometre 9.4 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.5474 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.36 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.7351 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.2975 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 114.0% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in IDA only?
- Access to anti-retroviral drugs, female in IDA only was 86.5% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in IDA only?
- The highest recorded value was 86.5% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in IDA only?
- The lowest recorded value was 0.0% in 2000.
- How does IDA only rank for access to anti-retroviral drugs, female?
- IDA only ranks 7th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in IDA only?
- Over the last ten years it is up 86.9%. The long-run trend across the full record is volatile.
- Where does this IDA only data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.